The ruling is the latest twist in a long-running dispute over where dozens of federally-supported former research chimps should live out the remainder of their days.
The U.S. agency that's supposed to protect workers' health has all but given up on setting limits on a dangerous chemical released in tire manufacturing. Meanwhile, workers are dying.
People are gathering indoors for the holidays, and there's been an uptick in COVID-19 cases. The federal government says you should test often to try to prevent the spread of the virus.
Two state employees and a public school media clerk are suing the state of Georgia. They say in a federal lawsuit filed Wednesday that the state employee health plan is illegally discriminating by refusing to pay for gender transition-related health care.
NPR asked a handful of public health experts how to approach a holiday season with not one but three respiratory pathogens helping fill hospitals: COVID, the flu and RSV.
What would a world without medical debt look like? In Germany's former coal-mining region medical debt is almost unknown, despite economic challenges and health problems. Here's why.
Can a 4-year-old go out alone? Why did a payphone in China keep ringing? Does stinky sweat have an upside? These are some of our non-pandemic global stories that drew the most readers in 2022.
China's National Health Commission is scaling down its daily COVID-19 report starting Wednesday after a sharp decline in PCR testing even though daily cases are hitting record highs.
Although the study authors say the results can't be used to gauge drug use on the roads nationwide, the high number of drivers, passengers and others with drugs in their systems is concerning.
Emergent BioSolutions has applied to the Food and Drug Administration to sell the opioid overdose-reversal drug over the counter. Addiction experts say it may be a key step to lower fentanyl deaths.
Winter can be hard, especially in the halls of healing. A doctor shares how this year's World Cup has become the holiday event she and others didn't know they needed.
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.
CVS would pay about $5 billion and Walgreens more than $5.5 billion, though neither company has admitted wrongdoing. States have until the end of the year to accept the terms of the settlement.
